So when the numbers are that high, it's not just for diabetes anymore, right
[PMID: 10208759] PubMed record related to this compound for laboratory literature review
Avoid shaking your semaglutide pen
In December 2024, Zepbound was the first medicine approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity
This is not an extensively studied area, and there are gaps in our knowledge. It may take years to understand the real impact of GLP-1 receptor agonists on pregnancy
Carolyn Bramante, who works in the weight management clinic at the University of Minnesota says she still uses metformin "quite often" for patients with a host of weight-related issues, including type 2 diabetes, pre-diabetes, and obesity, too